The Cancer Moonshot: Increasing cancer survivorship for everyone

<p>With the goal of cutting cancer deaths in half by 2047, the White House's Cancer Moonshot initiative is pumping $1.8 billion into cancer research over the next seven years. Achieving this goal, however, will require clearing research hurdles — including the lack of diversity in clinical trials, say <a href='https://www.northwell.edu/about/leadership/richard-barakat-md'>Richard Barakat, MD</a>, and <a href='https://www.cshl.edu/research/faculty-staff/david-tuveson/'>David Tuveson, MD, PhD</a>. They discuss the exciting research being funded by the Moonshot initiative, describe efforts to improve and diversify clinical trial recruitment, and explain the fruitful collaboration between Northwell Health and Cold Spring Harbor.</p> <p>Chapters:</p> <ul><li>01:33 - What is the Cancer Moonshot?</li> <li>02:16 - Replicating success, speed of Covid-19 vaccine development</li> <li>03:46 - Allocating funds</li> <li>06:41 - The pre-neoplasia project</li> <li>09:48 - Pushing for greater access</li> <li>11:23 - Cancer disparities, outcomes</li> <li>12:55 - Community outreach is critical</li> <li>14:25 - Commitment to cancer research</li> <li>16:26 - Practice changing, paradigm shifting, policy making</li> <li>19:30 - Can we cut mortality by 50 percent? </li> </ul> <p>Meet the experts</p> <p>Richard Barakat, MD, Northwell Cancer Institute</p> <p>David Tuveson, MD, PhD, Professor, Director, Cancer Center, Cold Spring Harbor</p>